BackNuvectis Pharma Overview

Nuvectis Pharma Minority Interest

Latest minority interest for NVCT: $0.

Get informed when a big investor buys or sells

+ Follow
Minority Interest
$0.00

Peer average / median

Loading

Nuvectis Pharma Minority Interest History

Loading

Nuvectis Pharma vs. peers: Minority Interest Comparison

Loading

Nuvectis Pharma Minority Interest Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

Nuvectis Pharma (NVCT) FAQ

As of the most recent data (June 2026), NVCT shows a minority interest of $0. In the prior-year period, the figure was $0. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, NVCT's minority interest is now $0 (was $0). Pairing that YoY change with peer averages gives a clearer picture of whether Nuvectis Pharma is outperforming or lagging.

Tracking NVCT's minority interest over time shows whether Nuvectis Pharma is scaling, shrinking, or reshaping that part of the business. The current reading is $0 In the prior-year period, the figure was $0. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this minority interest page, Stockcircle has Nuvectis Pharma's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect minority interest (currently $0) with ownership activity and broader fundamentals.